keyword
https://read.qxmd.com/read/36739655/cardiovascular-disease-in-asthma-patients-from-mechanisms-to-therapeutic-implications
#1
JOURNAL ARTICLE
Mario Cazzola, Nicola A Hanania, Paola Rogliani, Maria Griella Matera
Cardiovascular disease (CVD) is often associated with asthma, and asthma patients have an increased risk of CVD mortality. Our understanding of the bidirectional risk of CVD and asthma has been based on several observational studies. However, the specific pathogenetic mechanisms underlying the development of cardiovascular comorbidities in patients with asthma have not yet been fully determined. Such cardiovascular complications in patients with asthma have been attributed to airway and system inflammation present in both asthma and CVD...
February 5, 2023: Kardiologia Polska
https://read.qxmd.com/read/36005853/neointimal-hyperplasia-in-systemic-to-pulmonary-shunts-of-children-with-complex-cyanotic-congenital-heart-disease
#2
JOURNAL ARTICLE
Philip Kottmann, Julie Cleuziou, Julia Lemmer, Katja Eildermann, Keti Vitanova, Maria von-Stumm, Luisa Lehmann, Juergen Horer, Peter Ewert, Matthias Sigler, Cordula M Wolf
OBJECTIVES: Neointimal hyperplasia might affect systemic-to-pulmonary shunt failure in infants with complex cyanotic congenital heart disease.The aim of this study was to elucidate histopathologic changes of polytetrafluorethylene shunts and to determine whether increased neointimal formation is associated with early interventions comprising balloon dilatation, stent implantation and shunt revision. Further, we intended to identify clinical factors associated with increased neointimal proliferation...
August 25, 2022: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/35355425/the-new-hfa-icos-risk-assessment-tool-to-identify-patients-with-chronic-myeloid-leukaemia-at-high-risk-of-cardiotoxicity
#3
JOURNAL ARTICLE
Daniela Di Lisi, Cristina Madaudo, Giulia Alagna, Marco Santoro, Ludovico Rossetto, Sergio Siragusa, Giuseppina Novo
AIMS: Tyrosine kinase inhibitors (TKIs) used to treat chronic myeloid leukaemia (CML) can cause cardiovascular adverse events. So far, the Systematic Coronary Risk Evaluation (SCORE) charts of the European Society of Cardiology (ESC) have been used to identify cancer patients at increased cardiovascular risk. The primary aim of our study was to evaluate the usefulness of the new cardiovascular risk assessment model proposed by the Cardio-Oncology Study Group of the Heart Failure Association (HFA) of the ESC in collaboration with the International Cardio-Oncology Society (ICOS) to stratify the cardiovascular risk in CML patients, compared with SCORE risk charts...
March 31, 2022: ESC Heart Failure
https://read.qxmd.com/read/34410528/pregnancy-associated-myocardial-infarction-a-review-of-current-practices-and-guidelines
#4
REVIEW
Anas Alameh, Ahmad Jabri, Wesam Aleyadeh, Farhan Nasser, Ahmad Al Abdouh, Meera Kondapaneni, Martha Gulati, Deirdre Mattina, Katherine Singh, Jennifer Hargrave, Eric E Roselli, Umesh N Khot, Leslie Cho, Ankur Kalra
PURPOSE OF REVIEW: Pregnancy-associated myocardial infarction is a principal cause of cardiovascular disease with a steadily rising incidence of 4.98 AMI events/100,000 deliveries over the last four decades in the USA. It is also linked with significant maternal and fetal morbidity and mortality, with maternal case fatality rate ranging from 5.1 to 37%. The management of acute myocardial infarction can be challenging in pregnant patients since treatment modalities and medication use are limited by their safety during pregnancy...
August 19, 2021: Current Cardiology Reports
https://read.qxmd.com/read/33613799/survival-benefit-of-aspirin-in-patients-with-congestive-heart-failure-a-meta-analysis
#5
JOURNAL ARTICLE
Sania Jiwani, Usman Mustafa, Sapna Desai, Paari Dominic
Background: There is no clear consensus on the use of aspirin (ASA) in patients with congestive heart failure (CHF) due to its reported interaction with other cardio-prudent medications. The aim was to evaluate the effect of ASA on all-cause mortality and the frequency of hospitalization for heart failure in patients with CHF using meta-analysis, as well as to study the potential variables interacting with this effect. Methods: Eligible studies were identified via a PubMed search, the "related article" feature and a manual search of references...
January 2021: Journal of Clinical Medicine Research
https://read.qxmd.com/read/25053883/risk-scores-and-geriatric-profile-can-they-really-help-us-in-anticoagulation-decision-making-among-older-patients-suffering-from-atrial-fibrillation
#6
JOURNAL ARTICLE
Frédéric Maes, Olivia Dalleur, Séverine Henrard, Dominique Wouters, Christophe Scavée, Anne Spinewine, Benoit Boland
OBJECTIVES: Anticoagulation for the prevention of cardio-embolism is most frequently indicated but largely underused in frail older patients with atrial fibrillation (AF). This study aimed at identifying characteristics associated with anticoagulation underuse. METHODS: A cross-sectional study of consecutive geriatric patients aged ≥75 years, with AF and clear anticoagulation indication (CHADS₂ [Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack] ≥2) upon hospital admission...
2014: Clinical Interventions in Aging
https://read.qxmd.com/read/23946761/pharmacologic-management-of-the-cardio-renal-syndrome
#7
JOURNAL ARTICLE
Chang Seong Kim
Cardio-renal syndromes are disorders of the heart and kidney wherein acute or long-term dysfunction in one organ may induce acute or long-term dysfunction of the other. Because of this complex organ interaction, management of cardiorenal syndrome must be tailored to the underlying pathophysiology. Clinical guidelines exist for the treatment of heart failure or renal failure as separate conditions. Thus far, however, there has been no consensus about managing patients with cardio-renal and reno-cardiac syndromes...
June 2013: Electrolyte & Blood Pressure: E & BP
https://read.qxmd.com/read/23603009/safe-use-of-alteplase-in-a-10-months-old-infant-with-cardio-embolic-stroke
#8
JOURNAL ARTICLE
Zvonka Rener-Primec, Viktor Švigelj, Samo Vesel, Dimitrij Lovrič, Andreja Škofljanec
The knowledge about safety and efficacy of thrombolysis in paediatric stroke is limited, especially for very young children. We present an infant with cardioembolic stroke treated with alteplase. He had hypoplastic left heart syndrome since birth. He underwent Norwood operation, followed by bidirectional cavopulmonary anastomosis at 3 months. On aspirin therapy he was well until heart failure developed at the age of 9 months with 2 thrombi in the right ventricle. During the course of enoxaparin therapy sudden acute left-sided haemiplegia occurred...
September 2013: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/12940539/the-cardio-renal-anemia-syndrome-correcting-anemia-in-patients-with-resistant-congestive-heart-failure-can-improve-both-cardiac-and-renal-function-and-reduce-hospitalizations
#9
REVIEW
D S Silverberg, D Wexler, M Blum, A Iaina
Anemia (Hemoglobin of < 12 to 13 g/dl) is frequently encountered in patients with congestive heart failure (CHF). This anemia may be partly due to hemodilution, partly to the associated reduction in renal function, and partly to the use of ACE inhibitors and aspirin. However, there is evidence that CHF alone--through excessive cytokine production may also reduce the bone marrow and cause anemia. In several recent studies anemia has been found to be associated with a more severe degree of CHF, a higher rate of death, renal failure, hospitalization and evidence of malnutrition...
July 2003: Clinical Nephrology
https://read.qxmd.com/read/12453537/the-importance-of-anemia-and-its-correction-in-the-management-of-severe-congestive-heart-failure
#10
REVIEW
Donald S Silverberg, Dov Wexler, Adrian Iaina
About half of all the patients with CHF are anemic (they have a hemoglobin of < 12 g%). The prevalence and severity of this anemia increase with increasing severity of the CHF. The anemia is caused by a combination of poor nutrition, associated renal insufficiency causing inappropriately low Erythropoietin (EPO) levels, bone marrow depression and EPO resistance caused by excessive TNF alpha and other factors, gastrointestinal blood loss caused by aspirin, ACE inhibitors, EPO loss in the urine with proteinuria, and hemodilution caused by the excessive plasma volume...
December 2002: European Journal of Heart Failure
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.